Comparison the efficacy of Tramadol and Diclofenac in the treatment of renal colic.
Not Applicable
Completed
- Conditions
- Renal colic.Urolithiasisn20-n23
- Registration Number
- IRCT201105293912N3
- Lead Sponsor
- Shahrekord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Inclusion Criteria :Patients with acute renal colic thats confirm with IVP,KUB.CT-Scan,Sonography.age between 15-65 years
Exclusion Criteria,pregnancy.asthma,allery ,hemorrhagic diseases,drug abuses.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: The pain severity will assessed before and then at 15,30,60 minute after drugs administration. Method of measurement: MacGill questionnaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Tramadol's analgesic effects in renal colic compared to Diclofenac's COX-2 inhibition?
How does Tramadol's efficacy in urolithiasis pain management compare to Diclofenac as a standard-of-care treatment?
Are there biomarkers predicting response to Tramadol versus Diclofenac in patients with n20-n23 urolithiasis subtypes?
What adverse event profiles distinguish Tramadol from Diclofenac in renal colic treatment and management strategies?
What combination therapies or competitor drugs show promise alongside Tramadol/Diclofenac for urolithiasis pain relief?